APO Research
Talk to an analyst

APO RESEARCH · REPORT

Metoclopramide Tablets

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Metoclopramide Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025198 pages

Choose your research edition.

Industry ResearchMetoclopramide Tablets Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Metoclopramide Tablets Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Metoclopramide Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Metoclopramide Tablets Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Metoclopramide Tablets Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Metoclopramide Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Metoclopramide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Metoclopramide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Metoclopramide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Metoclopramide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Metoclopramide Tablets include Yabao Pharmaceutical Group Co., Ltd., Xi'an Fenghua Pharmaceutical Co., Ltd., Tianjin Lisheng Pharmaceutical Co., Ltd., Taosheng Pharmaceutical Co., Ltd., Shijiazhuang Dongfang Pharmaceutical Co., Ltd., Shanghai Jinbuhuan Lankao Pharmaceutical Co., Ltd., Shaanxi Han Tang Pharmaceutical Co., Ltd., Shanxi Guorun Pharmaceutical Co., Ltd. and Shandong Xinhua Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Metoclopramide Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Metoclopramide Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Metoclopramide Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Metoclopramide Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Metoclopramide Tablets Segment by Company

Yabao Pharmaceutical Group Co., Ltd.

Xi'an Fenghua Pharmaceutical Co., Ltd.

Tianjin Lisheng Pharmaceutical Co., Ltd.

Taosheng Pharmaceutical Co., Ltd.

Shijiazhuang Dongfang Pharmaceutical Co., Ltd.

Shanghai Jinbuhuan Lankao Pharmaceutical Co., Ltd.

Shaanxi Han Tang Pharmaceutical Co., Ltd.

Shanxi Guorun Pharmaceutical Co., Ltd.

Shandong Xinhua Pharmaceutical Co., Ltd.

Liaoning Ludan Pharmaceutical Co., Ltd.

Jiangsu Jibei Pharmaceutical Co., Ltd.

Jinan Hengji Pharmaceutical Co., Ltd.

Jilin Jinheng Pharmaceutical Co., Ltd.

Henan Runhong Pharmaceutical Co., Ltd.

Sinopharm Group Guorui Pharmaceutical Co., Ltd.

Beijing Zhongxin Pharmaceutical Co., Ltd.

Beijing Taiyang Pharmaceutical Co., Ltd.

Anhui Huachen Pharmaceutical Co., Ltd.

Anhui Dongsheng Youbang Pharmaceutical Co., Ltd.

Metoclopramide Tablets Segment by Type

5mg

10mg

Metoclopramide Tablets Segment by Application

Online e-commerce

Pharmacy

Hospital

Other

Metoclopramide Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metoclopramide Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Metoclopramide Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metoclopramide Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Metoclopramide Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Metoclopramide Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Metoclopramide Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Metoclopramide Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Metoclopramide Tablets Industry Trends Table 2. Metoclopramide Tablets Industry Drivers Table 3. Metoclopramide Tablets Industry Opportunities and Challenges Table 4. Metoclopramide Tablets Industry Restraints Table 5. Global Metoclopramide Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Metoclopramide Tablets Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Metoclopramide Tablets Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Metoclopramide Tablets Sales Market Share by Manufacturers Table 9. Global Metoclopramide Tablets Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Metoclopramide Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Metoclopramide Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Metoclopramide Tablets Manufacturers, Product Type & Application Table 13. Global Metoclopramide Tablets Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Metoclopramide Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 5mg Table 17. Major Manufacturers of 10mg Table 18. Global Metoclopramide Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Metoclopramide Tablets Sales by Type (2021-2026) & (K Units) Table 20. Global Metoclopramide Tablets Sales by Type (2027-2032) & (K Units) Table 21. Global Metoclopramide Tablets Sales Market Share by Type (2021-2026) Table 22. Global Metoclopramide Tablets Sales Market Share by Type (2027-2032) Table 23. Global Metoclopramide Tablets Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Metoclopramide Tablets Revenue by Type (2021-2026) & (K Units) Table 25. Global Metoclopramide Tablets Revenue by Type (2027-2032) & (K Units) Table 26. Global Metoclopramide Tablets Revenue Market Share by Type (2021-2026) Table 27. Global Metoclopramide Tablets Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Online e-commerce Table 29. Major Manufacturers of Pharmacy Table 30. Major Manufacturers of Hospital Table 31. Major Manufacturers of Other Table 32. Global Metoclopramide Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Metoclopramide Tablets Sales by Application (2021-2026) & (K Units) Table 34. Global Metoclopramide Tablets Sales by Application (2027-2032) & (K Units) Table 35. Global Metoclopramide Tablets Sales Market Share by Application (2021-2026) Table 36. Global Metoclopramide Tablets Sales Market Share by Application (2027-2032) Table 37. Global Metoclopramide Tablets Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Metoclopramide Tablets Revenue by Application (2021-2026) & (K Units) Table 39. Global Metoclopramide Tablets Revenue by Application (2027-2032) & (K Units) Table 40. Global Metoclopramide Tablets Revenue Market Share by Application (2021-2026) Table 41. Global Metoclopramide Tablets Revenue Market Share by Application (2027-2032) Table 42. Global Metoclopramide Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Metoclopramide Tablets Sales by Region (2021-2026) & (K Units) Table 44. Global Metoclopramide Tablets Sales Market Share by Region (2021-2026) Table 45. Global Metoclopramide Tablets Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Metoclopramide Tablets Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Metoclopramide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Metoclopramide Tablets Sales by Country (2021-2026) & (K Units) Table 49. North America Metoclopramide Tablets Sales by Country (2027-2032) & (K Units) Table 50. Europe Metoclopramide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Metoclopramide Tablets Sales by Country (2021-2026) & (K Units) Table 52. Europe Metoclopramide Tablets Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Metoclopramide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Metoclopramide Tablets Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Metoclopramide Tablets Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Metoclopramide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Metoclopramide Tablets Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Metoclopramide Tablets Sales by Country (2027-2032) & (K Units) Table 59. Global Metoclopramide Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Metoclopramide Tablets Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Metoclopramide Tablets Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Metoclopramide Tablets Revenue Market Share by Region (2021-2026) Table 63. Global Metoclopramide Tablets Revenue Market Share by Region (2027-2032) Table 64. Yabao Pharmaceutical Group Co., Ltd. Company Information Table 65. Yabao Pharmaceutical Group Co., Ltd. Business Overview Table 66. Yabao Pharmaceutical Group Co., Ltd. Metoclopramide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Yabao Pharmaceutical Group Co., Ltd. Metoclopramide Tablets Product Portfolio Table 68. Yabao Pharmaceutical Group Co., Ltd. Recent Development Table 69. Xi'an Fenghua Pharmaceutical Co., Ltd. Company Information Table 70. Xi'an Fenghua Pharmaceutical Co., Ltd. Business Overview Table 71. Xi'an Fenghua Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Xi'an Fenghua Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio Table 73. Xi'an Fenghua Pharmaceutical Co., Ltd. Recent Development Table 74. Tianjin Lisheng Pharmaceutical Co., Ltd. Company Information Table 75. Tianjin Lisheng Pharmaceutical Co., Ltd. Business Overview Table 76. Tianjin Lisheng Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Tianjin Lisheng Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio Table 78. Tianjin Lisheng Pharmaceutical Co., Ltd. Recent Development Table 79. Taosheng Pharmaceutical Co., Ltd. Company Information Table 80. Taosheng Pharmaceutical Co., Ltd. Business Overview Table 81. Taosheng Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Taosheng Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio Table 83. Taosheng Pharmaceutical Co., Ltd. Recent Development Table 84. Shijiazhuang Dongfang Pharmaceutical Co., Ltd. Company Information Table 85. Shijiazhuang Dongfang Pharmaceutical Co., Ltd. Business Overview Table 86. Shijiazhuang Dongfang Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Shijiazhuang Dongfang Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio Table 88. Shijiazhuang Dongfang Pharmaceutical Co., Ltd. Recent Development Table 89. Shanghai Jinbuhuan Lankao Pharmaceutical Co., Ltd. Company Information Table 90. Shanghai Jinbuhuan Lankao Pharmaceutical Co., Ltd. Business Overview Table 91. Shanghai Jinbuhuan Lankao Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Shanghai Jinbuhuan Lankao Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio Table 93. Shanghai Jinbuhuan Lankao Pharmaceutical Co., Ltd. Recent Development Table 94. Shaanxi Han Tang Pharmaceutical Co., Ltd. Company Information Table 95. Shaanxi Han Tang Pharmaceutical Co., Ltd. Business Overview Table 96. Shaanxi Han Tang Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Shaanxi Han Tang Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio Table 98. Shaanxi Han Tang Pharmaceutical Co., Ltd. Recent Development Table 99. Shanxi Guorun Pharmaceutical Co., Ltd. Company Information Table 100. Shanxi Guorun Pharmaceutical Co., Ltd. Business Overview Table 101. Shanxi Guorun Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Shanxi Guorun Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio Table 103. Shanxi Guorun Pharmaceutical Co., Ltd. Recent Development Table 104. Shandong Xinhua Pharmaceutical Co., Ltd. Company Information Table 105. Shandong Xinhua Pharmaceutical Co., Ltd. Business Overview Table 106. Shandong Xinhua Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Shandong Xinhua Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio Table 108. Shandong Xinhua Pharmaceutical Co., Ltd. Recent Development Table 109. Liaoning Ludan Pharmaceutical Co., Ltd. Company Information Table 110. Liaoning Ludan Pharmaceutical Co., Ltd. Business Overview Table 111. Liaoning Ludan Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Liaoning Ludan Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio Table 113. Liaoning Ludan Pharmaceutical Co., Ltd. Recent Development Table 114. Jiangsu Jibei Pharmaceutical Co., Ltd. Company Information Table 115. Jiangsu Jibei Pharmaceutical Co., Ltd. Business Overview Table 116. Jiangsu Jibei Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Jiangsu Jibei Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio Table 118. Jiangsu Jibei Pharmaceutical Co., Ltd. Recent Development Table 119. Jinan Hengji Pharmaceutical Co., Ltd. Company Information Table 120. Jinan Hengji Pharmaceutical Co., Ltd. Business Overview Table 121. Jinan Hengji Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Jinan Hengji Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio Table 123. Jinan Hengji Pharmaceutical Co., Ltd. Recent Development Table 124. Jilin Jinheng Pharmaceutical Co., Ltd. Company Information Table 125. Jilin Jinheng Pharmaceutical Co., Ltd. Business Overview Table 126. Jilin Jinheng Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Jilin Jinheng Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio Table 128. Jilin Jinheng Pharmaceutical Co., Ltd. Recent Development Table 129. Henan Runhong Pharmaceutical Co., Ltd. Company Information Table 130. Henan Runhong Pharmaceutical Co., Ltd. Business Overview Table 131. Henan Runhong Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Henan Runhong Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio Table 133. Henan Runhong Pharmaceutical Co., Ltd. Recent Development Table 134. Sinopharm Group Guorui Pharmaceutical Co., Ltd. Company Information Table 135. Sinopharm Group Guorui Pharmaceutical Co., Ltd. Business Overview Table 136. Sinopharm Group Guorui Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Sinopharm Group Guorui Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio Table 138. Sinopharm Group Guorui Pharmaceutical Co., Ltd. Recent Development Table 139. Beijing Zhongxin Pharmaceutical Co., Ltd. Company Information Table 140. Beijing Zhongxin Pharmaceutical Co., Ltd. Business Overview Table 141. Beijing Zhongxin Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. Beijing Zhongxin Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio Table 143. Beijing Zhongxin Pharmaceutical Co., Ltd. Recent Development Table 144. Beijing Taiyang Pharmaceutical Co., Ltd. Company Information Table 145. Beijing Taiyang Pharmaceutical Co., Ltd. Business Overview Table 146. Beijing Taiyang Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 147. Beijing Taiyang Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio Table 148. Beijing Taiyang Pharmaceutical Co., Ltd. Recent Development Table 149. Anhui Huachen Pharmaceutical Co., Ltd. Company Information Table 150. Anhui Huachen Pharmaceutical Co., Ltd. Business Overview Table 151. Anhui Huachen Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 152. Anhui Huachen Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio Table 153. Anhui Huachen Pharmaceutical Co., Ltd. Recent Development Table 154. Anhui Dongsheng Youbang Pharmaceutical Co., Ltd. Company Information Table 155. Anhui Dongsheng Youbang Pharmaceutical Co., Ltd. Business Overview Table 156. Anhui Dongsheng Youbang Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 157. Anhui Dongsheng Youbang Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio Table 158. Anhui Dongsheng Youbang Pharmaceutical Co., Ltd. Recent Development Table 159. Key Raw Materials Table 160. Raw Materials Key Suppliers Table 161. Metoclopramide Tablets Distributors List Table 162. Metoclopramide Tablets Customers List Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources Table 166. Primary Sources List of Figures Figure 1. Metoclopramide Tablets Product Image Figure 2. Global Metoclopramide Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Metoclopramide Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Metoclopramide Tablets Sales (2021-2032) & (K Units) Figure 5. Global Metoclopramide Tablets Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Metoclopramide Tablets Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 5mg Image Figure 9. 10mg Image Figure 10. Global Metoclopramide Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Metoclopramide Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Metoclopramide Tablets Sales Market Share by Type (2021-2032) Figure 13. Global Metoclopramide Tablets Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Metoclopramide Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Metoclopramide Tablets Revenue Market Share by Type (2021-2032) Figure 16. Online e-commerce Image Figure 17. Pharmacy Image Figure 18. Hospital Image Figure 19. Other Image Figure 20. Global Metoclopramide Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Metoclopramide Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Metoclopramide Tablets Sales Market Share by Application (2021-2032) Figure 23. Global Metoclopramide Tablets Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Metoclopramide Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Metoclopramide Tablets Revenue Market Share by Application (2021-2032) Figure 26. North America Metoclopramide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Metoclopramide Tablets Sales Market Share by Country (2021-2032) Figure 28. U.S. Metoclopramide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Metoclopramide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Metoclopramide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Metoclopramide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Metoclopramide Tablets Sales Market Share by Country (2021-2032) Figure 33. Germany Metoclopramide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Metoclopramide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Metoclopramide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Metoclopramide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Metoclopramide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Metoclopramide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Metoclopramide Tablets Sales Market Share by Country (2021-2032) Figure 40. China Metoclopramide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Metoclopramide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Metoclopramide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Metoclopramide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Metoclopramide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Metoclopramide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Metoclopramide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Metoclopramide Tablets Sales Market Share by Country (2021-2032) Figure 48. Brazil Metoclopramide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Metoclopramide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Metoclopramide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Metoclopramide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Metoclopramide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Metoclopramide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Metoclopramide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Metoclopramide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Metoclopramide Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Metoclopramide Tablets Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Metoclopramide Tablets Revenue (2021-2032) & (US$ Million) Figure 59. North America Metoclopramide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Metoclopramide Tablets Revenue (2021-2032) & (US$ Million) Figure 61. Europe Metoclopramide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Metoclopramide Tablets Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Metoclopramide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Metoclopramide Tablets Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Metoclopramide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Metoclopramide Tablets Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Metoclopramide Tablets Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 5mg
  • 10mg
Applications
  • Online e-commerce
  • Pharmacy
  • Hospital
  • Other
Companies covered
  • Yabao Pharmaceutical Group Co., Ltd.
  • Xi'an Fenghua Pharmaceutical Co., Ltd.
  • Tianjin Lisheng Pharmaceutical Co., Ltd.
  • Taosheng Pharmaceutical Co., Ltd.
  • Shijiazhuang Dongfang Pharmaceutical Co., Ltd.
  • Shanghai Jinbuhuan Lankao Pharmaceutical Co., Ltd.
  • Shaanxi Han Tang Pharmaceutical Co., Ltd.
  • Shanxi Guorun Pharmaceutical Co., Ltd.
  • Shandong Xinhua Pharmaceutical Co., Ltd.
  • Liaoning Ludan Pharmaceutical Co., Ltd.
  • Jiangsu Jibei Pharmaceutical Co., Ltd.
  • Jinan Hengji Pharmaceutical Co., Ltd.
  • Jilin Jinheng Pharmaceutical Co., Ltd.
  • Henan Runhong Pharmaceutical Co., Ltd.
  • Sinopharm Group Guorui Pharmaceutical Co., Ltd.
  • Beijing Zhongxin Pharmaceutical Co., Ltd.
  • Beijing Taiyang Pharmaceutical Co., Ltd.
  • Anhui Huachen Pharmaceutical Co., Ltd.
  • Anhui Dongsheng Youbang Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Metoclopramide Tablets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Metoclopramide Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Metoclopramide Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Metoclopramide Tablets Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Metoclopramide Tablets Market Dynamics
  1. 2.1 Metoclopramide Tablets Industry Trends
  2. 2.2 Metoclopramide Tablets Industry Drivers
  3. 2.3 Metoclopramide Tablets Industry Opportunities and Challenges
  4. 2.4 Metoclopramide Tablets Industry Restraints
3 Metoclopramide Tablets Market by Manufacturers
  1. 3.1 Global Metoclopramide Tablets Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Metoclopramide Tablets Sales by Manufacturers (2021-2026)
  3. 3.3 Global Metoclopramide Tablets Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Metoclopramide Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Metoclopramide Tablets Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Metoclopramide Tablets Manufacturers, Product Type & Application
  7. 3.7 Global Metoclopramide Tablets Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Metoclopramide Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Metoclopramide Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Metoclopramide Tablets Tier 1, Tier 2, and Tier 3
4 Metoclopramide Tablets Market by Type
  1. 4.1 Metoclopramide Tablets Type Introduction
  2. 4.1.1 5mg
  3. 4.1.2 10mg
  4. 4.2 Global Metoclopramide Tablets Sales by Type
  5. 4.2.1 Global Metoclopramide Tablets Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Metoclopramide Tablets Sales by Type (2021-2032)
  7. 4.2.3 Global Metoclopramide Tablets Sales Market Share by Type (2021-2032)
  8. 4.3 Global Metoclopramide Tablets Revenue by Type
  9. 4.3.1 Global Metoclopramide Tablets Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Metoclopramide Tablets Revenue by Type (2021-2032)
  11. 4.3.3 Global Metoclopramide Tablets Revenue Market Share by Type (2021-2032)
5 Metoclopramide Tablets Market by Application
  1. 5.1 Metoclopramide Tablets Application Introduction
  2. 5.1.1 Online e-commerce
  3. 5.1.2 Pharmacy
  4. 5.1.3 Hospital
  5. 5.1.4 Other
  6. 5.2 Global Metoclopramide Tablets Sales by Application
  7. 5.2.1 Global Metoclopramide Tablets Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Metoclopramide Tablets Sales by Application (2021-2032)
  9. 5.2.3 Global Metoclopramide Tablets Sales Market Share by Application (2021-2032)
  10. 5.3 Global Metoclopramide Tablets Revenue by Application
  11. 5.3.1 Global Metoclopramide Tablets Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Metoclopramide Tablets Revenue by Application (2021-2032)
  13. 5.3.3 Global Metoclopramide Tablets Revenue Market Share by Application (2021-2032)
6 Global Metoclopramide Tablets Sales by Region
  1. 6.1 Global Metoclopramide Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Metoclopramide Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Metoclopramide Tablets Sales by Region (2021-2026)
  4. 6.2.2 Global Metoclopramide Tablets Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Metoclopramide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Metoclopramide Tablets Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Metoclopramide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Metoclopramide Tablets Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Metoclopramide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Metoclopramide Tablets Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Metoclopramide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Metoclopramide Tablets Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Metoclopramide Tablets Revenue by Region
  1. 7.1 Global Metoclopramide Tablets Revenue by Region
  2. 7.1.1 Global Metoclopramide Tablets Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Metoclopramide Tablets Revenue by Region (2021-2026)
  4. 7.1.3 Global Metoclopramide Tablets Revenue by Region (2027-2032)
  5. 7.1.4 Global Metoclopramide Tablets Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Metoclopramide Tablets Revenue (2021-2032)
  8. 7.2.2 North America Metoclopramide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Metoclopramide Tablets Revenue (2021-2032)
  11. 7.3.2 Europe Metoclopramide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Metoclopramide Tablets Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Metoclopramide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Metoclopramide Tablets Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Metoclopramide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Yabao Pharmaceutical Group Co., Ltd.
  2. 8.1.1 Yabao Pharmaceutical Group Co., Ltd. Company Information
  3. 8.1.2 Yabao Pharmaceutical Group Co., Ltd. Business Overview
  4. 8.1.3 Yabao Pharmaceutical Group Co., Ltd. Metoclopramide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Yabao Pharmaceutical Group Co., Ltd. Metoclopramide Tablets Product Portfolio
  6. 8.1.5 Yabao Pharmaceutical Group Co., Ltd. Recent Developments
  7. 8.2 Xi'an Fenghua Pharmaceutical Co., Ltd.
  8. 8.2.1 Xi'an Fenghua Pharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Xi'an Fenghua Pharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Xi'an Fenghua Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Xi'an Fenghua Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio
  12. 8.2.5 Xi'an Fenghua Pharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Tianjin Lisheng Pharmaceutical Co., Ltd.
  14. 8.3.1 Tianjin Lisheng Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Tianjin Lisheng Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Tianjin Lisheng Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Tianjin Lisheng Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio
  18. 8.3.5 Tianjin Lisheng Pharmaceutical Co., Ltd. Recent Developments
  19. 8.4 Taosheng Pharmaceutical Co., Ltd.
  20. 8.4.1 Taosheng Pharmaceutical Co., Ltd. Company Information
  21. 8.4.2 Taosheng Pharmaceutical Co., Ltd. Business Overview
  22. 8.4.3 Taosheng Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Taosheng Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio
  24. 8.4.5 Taosheng Pharmaceutical Co., Ltd. Recent Developments
  25. 8.5 Shijiazhuang Dongfang Pharmaceutical Co., Ltd.
  26. 8.5.1 Shijiazhuang Dongfang Pharmaceutical Co., Ltd. Company Information
  27. 8.5.2 Shijiazhuang Dongfang Pharmaceutical Co., Ltd. Business Overview
  28. 8.5.3 Shijiazhuang Dongfang Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Shijiazhuang Dongfang Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio
  30. 8.5.5 Shijiazhuang Dongfang Pharmaceutical Co., Ltd. Recent Developments
  31. 8.6 Shanghai Jinbuhuan Lankao Pharmaceutical Co., Ltd.
  32. 8.6.1 Shanghai Jinbuhuan Lankao Pharmaceutical Co., Ltd. Company Information
  33. 8.6.2 Shanghai Jinbuhuan Lankao Pharmaceutical Co., Ltd. Business Overview
  34. 8.6.3 Shanghai Jinbuhuan Lankao Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Shanghai Jinbuhuan Lankao Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio
  36. 8.6.5 Shanghai Jinbuhuan Lankao Pharmaceutical Co., Ltd. Recent Developments
  37. 8.7 Shaanxi Han Tang Pharmaceutical Co., Ltd.
  38. 8.7.1 Shaanxi Han Tang Pharmaceutical Co., Ltd. Company Information
  39. 8.7.2 Shaanxi Han Tang Pharmaceutical Co., Ltd. Business Overview
  40. 8.7.3 Shaanxi Han Tang Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Shaanxi Han Tang Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio
  42. 8.7.5 Shaanxi Han Tang Pharmaceutical Co., Ltd. Recent Developments
  43. 8.8 Shanxi Guorun Pharmaceutical Co., Ltd.
  44. 8.8.1 Shanxi Guorun Pharmaceutical Co., Ltd. Company Information
  45. 8.8.2 Shanxi Guorun Pharmaceutical Co., Ltd. Business Overview
  46. 8.8.3 Shanxi Guorun Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Shanxi Guorun Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio
  48. 8.8.5 Shanxi Guorun Pharmaceutical Co., Ltd. Recent Developments
  49. 8.9 Shandong Xinhua Pharmaceutical Co., Ltd.
  50. 8.9.1 Shandong Xinhua Pharmaceutical Co., Ltd. Company Information
  51. 8.9.2 Shandong Xinhua Pharmaceutical Co., Ltd. Business Overview
  52. 8.9.3 Shandong Xinhua Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Shandong Xinhua Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio
  54. 8.9.5 Shandong Xinhua Pharmaceutical Co., Ltd. Recent Developments
  55. 8.10 Liaoning Ludan Pharmaceutical Co., Ltd.
  56. 8.10.1 Liaoning Ludan Pharmaceutical Co., Ltd. Company Information
  57. 8.10.2 Liaoning Ludan Pharmaceutical Co., Ltd. Business Overview
  58. 8.10.3 Liaoning Ludan Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Liaoning Ludan Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio
  60. 8.10.5 Liaoning Ludan Pharmaceutical Co., Ltd. Recent Developments
  61. 8.11 Jiangsu Jibei Pharmaceutical Co., Ltd.
  62. 8.11.1 Jiangsu Jibei Pharmaceutical Co., Ltd. Company Information
  63. 8.11.2 Jiangsu Jibei Pharmaceutical Co., Ltd. Business Overview
  64. 8.11.3 Jiangsu Jibei Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Jiangsu Jibei Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio
  66. 8.11.5 Jiangsu Jibei Pharmaceutical Co., Ltd. Recent Developments
  67. 8.12 Jinan Hengji Pharmaceutical Co., Ltd.
  68. 8.12.1 Jinan Hengji Pharmaceutical Co., Ltd. Company Information
  69. 8.12.2 Jinan Hengji Pharmaceutical Co., Ltd. Business Overview
  70. 8.12.3 Jinan Hengji Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Jinan Hengji Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio
  72. 8.12.5 Jinan Hengji Pharmaceutical Co., Ltd. Recent Developments
  73. 8.13 Jilin Jinheng Pharmaceutical Co., Ltd.
  74. 8.13.1 Jilin Jinheng Pharmaceutical Co., Ltd. Company Information
  75. 8.13.2 Jilin Jinheng Pharmaceutical Co., Ltd. Business Overview
  76. 8.13.3 Jilin Jinheng Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Jilin Jinheng Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio
  78. 8.13.5 Jilin Jinheng Pharmaceutical Co., Ltd. Recent Developments
  79. 8.14 Henan Runhong Pharmaceutical Co., Ltd.
  80. 8.14.1 Henan Runhong Pharmaceutical Co., Ltd. Company Information
  81. 8.14.2 Henan Runhong Pharmaceutical Co., Ltd. Business Overview
  82. 8.14.3 Henan Runhong Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Henan Runhong Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio
  84. 8.14.5 Henan Runhong Pharmaceutical Co., Ltd. Recent Developments
  85. 8.15 Sinopharm Group Guorui Pharmaceutical Co., Ltd.
  86. 8.15.1 Sinopharm Group Guorui Pharmaceutical Co., Ltd. Company Information
  87. 8.15.2 Sinopharm Group Guorui Pharmaceutical Co., Ltd. Business Overview
  88. 8.15.3 Sinopharm Group Guorui Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Sinopharm Group Guorui Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio
  90. 8.15.5 Sinopharm Group Guorui Pharmaceutical Co., Ltd. Recent Developments
  91. 8.16 Beijing Zhongxin Pharmaceutical Co., Ltd.
  92. 8.16.1 Beijing Zhongxin Pharmaceutical Co., Ltd. Company Information
  93. 8.16.2 Beijing Zhongxin Pharmaceutical Co., Ltd. Business Overview
  94. 8.16.3 Beijing Zhongxin Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Beijing Zhongxin Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio
  96. 8.16.5 Beijing Zhongxin Pharmaceutical Co., Ltd. Recent Developments
  97. 8.17 Beijing Taiyang Pharmaceutical Co., Ltd.
  98. 8.17.1 Beijing Taiyang Pharmaceutical Co., Ltd. Company Information
  99. 8.17.2 Beijing Taiyang Pharmaceutical Co., Ltd. Business Overview
  100. 8.17.3 Beijing Taiyang Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Beijing Taiyang Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio
  102. 8.17.5 Beijing Taiyang Pharmaceutical Co., Ltd. Recent Developments
  103. 8.18 Anhui Huachen Pharmaceutical Co., Ltd.
  104. 8.18.1 Anhui Huachen Pharmaceutical Co., Ltd. Company Information
  105. 8.18.2 Anhui Huachen Pharmaceutical Co., Ltd. Business Overview
  106. 8.18.3 Anhui Huachen Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Anhui Huachen Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio
  108. 8.18.5 Anhui Huachen Pharmaceutical Co., Ltd. Recent Developments
  109. 8.19 Anhui Dongsheng Youbang Pharmaceutical Co., Ltd.
  110. 8.19.1 Anhui Dongsheng Youbang Pharmaceutical Co., Ltd. Company Information
  111. 8.19.2 Anhui Dongsheng Youbang Pharmaceutical Co., Ltd. Business Overview
  112. 8.19.3 Anhui Dongsheng Youbang Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Anhui Dongsheng Youbang Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio
  114. 8.19.5 Anhui Dongsheng Youbang Pharmaceutical Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Metoclopramide Tablets Value Chain Analysis
  2. 9.1.1 Metoclopramide Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Metoclopramide Tablets Production Mode & Process
  6. 9.2 Metoclopramide Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Metoclopramide Tablets Distributors
  9. 9.2.3 Metoclopramide Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst